Canagliflozin

Canagliflozin

CAT N°: 11575
Price:

From 85.00 72.25

Canagliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 2.2 nM) that less potently blocks SGLT1 (IC50 = 910 nM).{18745} Canagliflozin is orally bioavailable and lowers plasma glucose by lowering the renal threshold for glucose and increasing urinary glucose excretion in animals.{18745,33510} Formulations containing SGLT2 inhibitors, including canagliflozin, are used to treat type 2 diabetes mellitus.{33509}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (1S)-1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol
  • Correlated keywords
    • JNJ24831754-ZAE JNJ24831754ZAE JNJ24831754-ZAE 24831754ZAE 28431754AAA JNJ28431754AAA JNJ-28431754-AAA TA7284 C-AMG SGLT-2
  • Product Overview:
    Canagliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 2.2 nM) that less potently blocks SGLT1 (IC50 = 910 nM).{18745} Canagliflozin is orally bioavailable and lowers plasma glucose by lowering the renal threshold for glucose and increasing urinary glucose excretion in animals.{18745,33510} Formulations containing SGLT2 inhibitors, including canagliflozin, are used to treat type 2 diabetes mellitus.{33509}

We also advise you